The media has reported just a few days back about the Madras High Court striking down a case filed by the pharma major Novartis about India’s patent regime not being compliant with TRIPS regime of the WTO. Novartis being a Swiss pharma major and that too when a Swiss dignitary was visiting
What exactly was at stake in the case?
Novartis manufactures a drug called Glivec, which is used for treatment of cancer. It was granted patent for this by
The government of
By going to court what Novartis was trying to do was force the making of laws by
UPDATE: As this is an important issue from every point of view, you should also be looking at experts' opinion. Take a look at it here. This debate is about granting patents for incremental innovation.